VIM and cancer: Another set of tri-marker (CD133/CD31/Vimentin)-iFISH which focused on the progenitor feature of the tumor demonstrated that cancer stem-like cells displayed a CD45-/CD31-/CD133+/Vimentin- phenotype (Figure 3H).